24 May 2013
Keywords: millennium, initiates, ph, iii, trial, velcade, usa
Article | 23 July 2007
The USA's Millennium Pharmaceuticals has initiated a randomized, multicenter, Phase III trial to determine the most effective Velcade
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 July 2007
6 August 2007
9 July 2007
© 2013 thepharmaletter.com